ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225 | +7.7% | 3,881 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $209 | +42.2% | 3,881 | +5.4% | 0.00% | +100.0% |
| Q1 2023 | $147 | -0.7% | 3,681 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $148 | -99.8% | 3,681 | +65.6% | 0.00% | +100.0% |
| Q3 2022 | $71,000 | +26.8% | 2,223 | +10.9% | 0.00% | 0.0% |
| Q1 2022 | $56,000 | -39.1% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $92,000 | +39.4% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $66,000 | -5.7% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $70,000 | -2.8% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $72,000 | +24.1% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $58,000 | +1.8% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $57,000 | -12.3% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $65,000 | -20.7% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $82,000 | -33.9% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $124,000 | -15.1% | 2,005 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $146,000 | -11.5% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $165,000 | +17.0% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $141,000 | +56.7% | 2,005 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $90,000 | -20.4% | 2,005 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $113,000 | +68.7% | 2,005 | +99.5% | 0.00% | 0.0% |
| Q2 2018 | $67,000 | +13.6% | 1,005 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $59,000 | -34.4% | 1,005 | -28.2% | 0.00% | 0.0% |
| Q4 2017 | $90,000 | -25.6% | 1,400 | -39.1% | 0.00% | 0.0% |
| Q3 2017 | $121,000 | +12.0% | 2,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $108,000 | -27.5% | 2,300 | -23.3% | 0.00% | -50.0% |
| Q1 2017 | $149,000 | -18.1% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $182,000 | -8.5% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $199,000 | +19.2% | 3,000 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $167,000 | +65.3% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $101,000 | -25.2% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $135,000 | -10.0% | 3,000 | -21.1% | 0.00% | 0.0% |
| Q3 2015 | $150,000 | -38.0% | 3,800 | -2.6% | 0.00% | -33.3% |
| Q2 2015 | $242,000 | -34.4% | 3,900 | -33.9% | 0.00% | -25.0% |
| Q1 2015 | $369,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |